Hypothesis

18 Matching Annotations

Aug 2026
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Targeting the CHD3 chromatin remodeler exploits a synthetic lethal vulnerability in dual SMARCA4/SMARCA2-deficient cancers via derepression of PARD3B

1
1. scibot 15 Aug 2026
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1038/s41698-026-01499-7
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC13469703/
Mar 2026
onlinelibrary.wiley.com onlinelibrary.wiley.com

Metabolome analysis identified exogenous cholesterol within lipid rafts that activate the Akt/mTOR signaling pathway in epithelial ovarian cancer

1
1. scibot 12 Mar 2026
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1002/ijc.70401
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/10.1002/ijc.70401
Feb 2026
onlinelibrary.wiley.com onlinelibrary.wiley.com

HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma

1
1. scibot 03 Feb 2026
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1002/ijc.70341
  
  Resource: (JCRB Cat# FDSC0027, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/full/10.1002/ijc.70341
Dec 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Inhibition of glycolysis and stimulation of mitochondrial biogenesis lead to increased ROS levels and cell death in HNF-1ß positive clear cell carcinoma

1
1. scibot 05 Dec 2025
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1038/s41419-025-08243-2
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12669797/
Aug 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Selective Alanine Transporter Utilization is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

1
1. scibot 05 Aug 2025
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1158/0008-5472.CAN-25-0654
  
  Resource: (JCRB Cat# FDSC0027, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12314749/
May 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

1-s2.0-S2589004225008168-main-html.html

1
1. scibot 18 May 2025
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1016/j.isci.2025.112555
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC12145850/
Feb 2025
aacrjournals.org aacrjournals.org

YAP1 suppression by ZDHHC7 is associated with ferroptosis resistance and poor prognosis in ovarian clear cell carcinoma

1
1. scibot 13 Feb 2025
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1158/1535-7163.MCT-24-0145
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

aacrjournals.org/mct/article/23/11/1652/749309/YAP1-Suppression-by-ZDHHC7-Is-Associated-with
Jan 2025
pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov

Efficacy of CBP/p300 Dual Inhibitors against De-repression of KREMEN2 in cBAF-Deficient Cancers

1
1. scibot 08 Jan 2025
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1158/2767-9764.CRC-24-0484
  
  Resource: (JCRB Cat# FDSC0027, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

pmc.ncbi.nlm.nih.gov/articles/PMC11701801/
Nov 2023
www.nature.com www.nature.com

Characterization of a fluorescence imaging probe that exploits metabolic dependency of ovarian clear cell carcinoma

1
1. scibot 26 Nov 2023
  
  in Public
  
  RRID: CVCL_1662
  
  DOI: 10.1038/s41598-023-47637-0
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @anisehay
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

nature.com/articles/s41598-023-47637-0
Apr 2023
www.sciencedirect.com www.sciencedirect.com

Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma

1
1. scibot 29 Apr 2023
  
  in Public
  
  RRID: CVCL_1662
  
  DOI: 10.1016/j.ygyno.2023.03.020
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @sofiakhan13
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0090825823001671
www.sciencedirect.com www.sciencedirect.com

Targeting the mevalonate pathway suppresses ARID1A-inactivated cancers by promoting pyroptosis

1
1. scibot 19 Apr 2023
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1016/j.ccell.2023.03.002
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610823000508
www.sciencedirect.com www.sciencedirect.com

Cell-to-cell variability in Myc dynamics drives transcriptional heterogeneity in cancer cells

1
1. scibot 15 Apr 2023
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1016/j.celrep.2023.112401
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124723004126
Feb 2023
onlinelibrary.wiley.com onlinelibrary.wiley.com

Combination therapy with bevacizumab and a CCR2 inhibitor for human ovarian cancer: An in vivo validation study

1
1. scibot 23 Feb 2023
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1002/cam4.5674
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

onlinelibrary.wiley.com/doi/10.1002/cam4.5674
Apr 2022
www.sciencedirect.com www.sciencedirect.com

Interrogation of cancer gene dependencies reveals paralog interactions of autosome and sex chromosome-encoded genes

1
1. scibot 14 Apr 2022
  
  in Public
  
  CVCL_1662
  
  DOI: 10.1016/j.celrep.2022.110636
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2211124722003886
Oct 2021
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Targeting the IRE1α/XBP1 Endoplasmic Reticulum Stress Response Pathway in ARID1A-Mutant Ovarian Cancers

1
1. scibot 20 Oct 2021
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1158/0008-5472.CAN-21-1545
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC8723353/
Aug 2021
www.sciencedirect.com www.sciencedirect.com

CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer

1
1. scibot 01 Aug 2021
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1016/j.ygyno.2019.11.004
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @ethanbadger
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662 RRIDCUR:Validated
Visit annotations in context

Tags

RRIDCUR:Validated

RRID:CVCL_1662

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0090825819316257
Jul 2021
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Untitled document

1
1. scibot 31 Jul 2021
  
  in Public
  
  CVCL_1662
  
  DOI: 10.1371/journal.pone.0182789
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC5552298/
Feb 2021
www.sciencedirect.com www.sciencedirect.com

CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer

1
1. scibot 24 Feb 2021
  
  in Public
  
  RRID:CVCL_1662
  
  DOI: 10.1016/j.ygyno.2019.11.004
  
  Resource: (JCRB Cat# IFO50315, RRID:CVCL_1662)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1662
  
  What is this?
  
  RRID:CVCL_1662
Visit annotations in context

Tags

RRID:CVCL_1662

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S0090825819316257